Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | Cost Effectiveness and Resource Allocation

Figure 1

From: Community-based DOTS and family member DOTS for TB control in Nepal: costs and cost-effectiveness

Figure 1

Effect of changes in treatment success rates and costs per patient registered on the cost-effectiveness of the family-based DOTS and community-based DOTS strategies. The figure presents the effect of changes in the treatment success rates (%) and costs per patient (US$) under the CBD strategy on the balance of cost-effectiveness between the FBD and CBD strategies. Note: The axes cross at the current treatment success rate (83%) and costs per patient (US$76.2) for the community-based DOTS strategy.

Back to article page